Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity E.m.ld Regulatory News (FEML)

Share Price Information for Fidelity E.m.ld (FEML)

Share Price is delayed by 15 minutes
Get Live Data
1,400.00    -12.00 (-0.85%)
Bid:
1,398.00
Ask:
1,404.00
Spread: 6.00 (0.429%)
Market Cap: £565.34m
FEML Live PriceLast checked at - London Stock Exchange

Intraday Fidelity E.m.ld Share Chart

Initiation from QuotedData

5 Feb 2026 13:15

RNS Number : 9306R
Fidelity Emerging Markets Limited
05 February 2026
 

Fidelity Emerging Markets - Initiation from QuotedData

5 February 2026

The long and short of emerging markets

Fidelity Emerging Markets Limited (FEML) gives investors access to a wide range of emerging market shares. The managers have a flexible approach, investing in companies of all sizes and spreading investments across different countries and sectors. A key feature is the use of both long and short positions, allowing the fund to benefit from opportunities in both strong and weaker companies.

Performance has been strong over the past year, supported by favourable conditions for emerging markets. The discount to net asset value (NAV) has also narrowed, and there is potential for it to reduce further if investor sentiment improves.

Full Research:

https://quoteddata.com/research/fidelity-emerging-markets-the-long-and-short-of-emerging-markets-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Fidelity Emerging Markets Limited, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSSFDIEMSEFE
Date   Source Headline
9th Feb 20268:00 amRNSNet Asset Value(s)
6th Feb 20267:55 amRNSNet Asset Value(s)
5th Feb 20265:26 pmPRNTransaction in Own Shares
5th Feb 20261:15 pmRNS-RInitiation from QuotedData
5th Feb 20268:01 amRNSNet Asset Value(s)
4th Feb 20265:12 pmPRNTransaction in Own Shares
4th Feb 20267:48 amRNSNet Asset Value(s)
3rd Feb 20263:52 pmPRNHolding(s) in Company
3rd Feb 20267:46 amRNSNet Asset Value(s)
2nd Feb 20263:22 pmPRNTotal Voting Rights
2nd Feb 20267:53 amRNSNet Asset Value(s)
30th Jan 20265:09 pmPRNTransaction in Own Shares
30th Jan 20267:42 amRNSNet Asset Value(s)
29th Jan 20267:42 amRNSNet Asset Value(s)
28th Jan 20267:48 amRNSNet Asset Value(s)
27th Jan 20267:35 amRNSNet Asset Value(s)
26th Jan 20265:19 pmPRNTransaction in Own Shares
26th Jan 20267:39 amRNSNet Asset Value(s)
23rd Jan 202612:39 pmPRNMonthly Factsheet as at 31 December 2025
23rd Jan 20267:39 amRNSNet Asset Value(s)
22nd Jan 20267:51 amRNSNet Asset Value(s)
21st Jan 20265:18 pmPRNTransaction in Own Shares
21st Jan 20267:50 amRNSNet Asset Value(s)
20th Jan 20265:10 pmPRNTransaction in Own Shares
20th Jan 20267:52 amRNSNet Asset Value(s)
19th Jan 20265:34 pmPRNTransaction in Own Shares
19th Jan 20267:43 amRNSNet Asset Value(s)
16th Jan 20265:10 pmPRNTransaction in Own Shares
16th Jan 20267:39 amRNSNet Asset Value(s)
15th Jan 20265:07 pmPRNTransaction in Own Shares
15th Jan 20267:39 amRNSNet Asset Value(s)
14th Jan 20264:59 pmPRNTransaction in Own Shares
14th Jan 20267:38 amRNSNet Asset Value(s)
13th Jan 20265:58 pmPRNTransaction in Own Shares
13th Jan 20267:42 amRNSNet Asset Value(s)
12th Jan 20265:05 pmPRNTransaction in Own Shares
12th Jan 20267:52 amRNSNet Asset Value(s)
9th Jan 20265:21 pmPRNTransaction in Own Shares
9th Jan 202612:39 pmPRNHolding(s) in Company
9th Jan 20267:38 amRNSNet Asset Value(s)
8th Jan 20265:22 pmPRNTransaction in Own Shares
8th Jan 20267:39 amRNSNet Asset Value(s)
7th Jan 20265:20 pmPRNTransaction in Own Shares
7th Jan 20267:35 amRNSNet Asset Value(s)
6th Jan 20265:06 pmPRNTransaction in Own Shares
6th Jan 20267:40 amRNSNet Asset Value(s)
5th Jan 20267:59 amRNSNet Asset Value(s)
2nd Jan 20265:13 pmPRNTransaction in Own Shares
2nd Jan 20261:51 pmPRNTotal Voting Rights
2nd Jan 20267:49 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.